Charles Swanton, MD, PhD | Authors

Understanding Complex Tumor Heterogeneity

August 21, 2013

While personalized medicine is seen as a way to target an individual cancer patient’s tumors, using targeted agents, immunotherapy, and chemotoxic drugs, researchers are increasingly finding that not only do the cancers of individuals vary widely, but that tumors within a patient can also be quite different at the molecular level.